-
1
-
-
0012471517
-
Clinical outcome measures for multiple sclerosis
-
Goodkin DE, Rudick RA, eds. London: Springer, in press
-
Weinshenker BG. Clinical outcome measures for multiple sclerosis. In: Goodkin DE, Rudick RA, eds. Multiple sclerosis: advances in clinical trial design, treatment, and future perspectives. London: Springer, 1996 (in press)
-
(1996)
Multiple Sclerosis: Advances in Clinical Trial Design, Treatment, and Future Perspectives
-
-
Weinshenker, B.G.1
-
3
-
-
0029059966
-
Subcommittee on motor neuron diseases of the World Federation of Neurology research group on neuromuscular diseases, Airlie House "Therapeutic trials in ALS" workshop contributors. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis
-
Munsat TL, Subcommittee on motor neuron diseases of the World Federation of Neurology research group on neuromuscular diseases, Airlie House "Therapeutic trials in ALS" workshop contributors. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. J Neurol Sci 1995;129:1-10
-
(1995)
J Neurol Sci
, vol.129
, pp. 1-10
-
-
Munsat, T.L.1
-
4
-
-
0023154612
-
Measuring change over time: Assessing the usefulness of evaluative instruments
-
Guyatt GH, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987;40:171-178
-
(1987)
J Chronic Dis
, vol.40
, pp. 171-178
-
-
Guyatt, G.H.1
Walter, S.2
Norman, G.3
-
5
-
-
0026878672
-
Importance of sensitivity to change as a criterion for selecting health status measures
-
Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A. Importance of sensitivity to change as a criterion for selecting health status measures. Qual Health Care 1992;1:89-93
-
(1992)
Qual Health Care
, vol.1
, pp. 89-93
-
-
Fitzpatrick, R.1
Ziebland, S.2
Jenkinson, C.3
Mowat, A.4
-
6
-
-
0027418515
-
Interferon β 1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
-
The IFNB Multiple Sclerosis Study Group. Interferon β 1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:655-661
-
(1993)
Neurology
, vol.43
, pp. 655-661
-
-
-
7
-
-
0008678962
-
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
-
Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996;39:285-294
-
(1996)
Ann Neurol
, vol.39
, pp. 285-294
-
-
Jacobs, L.D.1
Cookfair, D.L.2
Rudick, R.A.3
-
8
-
-
0029082566
-
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo controlled trial
-
Johnson KP, Brooks BR, Ford CC, et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo controlled trial. Neurology 1995;45:1268-1276
-
(1995)
Neurology
, vol.45
, pp. 1268-1276
-
-
Johnson, K.P.1
Brooks, B.R.2
Ford, C.C.3
-
9
-
-
0001390488
-
On the evaluation of disability evaluation in multiple sclerosis
-
Kurtzke JF. On the evaluation of disability evaluation in multiple sclerosis. Neurology 1961;11:686-694
-
(1961)
Neurology
, vol.11
, pp. 686-694
-
-
Kurtzke, J.F.1
-
10
-
-
0025374249
-
VA Cooperative Study Group on Cochlear Implantation. Use of principal components analysis to develop a composite score as a primary outcome variable in a clinical trial
-
Henderson WG, Fisher SG, Cohen N, et al, VA Cooperative Study Group on Cochlear Implantation. Use of principal components analysis to develop a composite score as a primary outcome variable in a clinical trial. Control Clin Trials 1990; 11:199-214
-
(1990)
Control Clin Trials
, vol.11
, pp. 199-214
-
-
Henderson, W.G.1
Fisher, S.G.2
Cohen, N.3
-
11
-
-
0014905557
-
Neurological impairment in multiple sclerosis and the disability status scale
-
Kurtzke JF. Neurological impairment in multiple sclerosis and the disability status scale. Acta Neurol Scand 1970;46:493-512
-
(1970)
Acta Neurol Scand
, vol.46
, pp. 493-512
-
-
Kurtzke, J.F.1
-
12
-
-
9544226542
-
Data reduction in large clinical trials
-
Dixon WJ, Kuzma JW. Data reduction in large clinical trials. Community Stat 1974;3:301-324
-
(1974)
Community Stat
, vol.3
, pp. 301-324
-
-
Dixon, W.J.1
Kuzma, J.W.2
-
13
-
-
21344477543
-
Neuroperformance evaluation of multiple sclerosis disease progression in a clinical trial: Implications for neurological outcomes
-
Syndulko K, Tourtellotte WW, Baumhefner RW, et al. Neuroperformance evaluation of multiple sclerosis disease progression in a clinical trial: implications for neurological outcomes. J Neural Rehabil 1993;7:153-176
-
(1993)
J Neural Rehabil
, vol.7
, pp. 153-176
-
-
Syndulko, K.1
Tourtellotte, W.W.2
Baumhefner, R.W.3
-
14
-
-
0024563870
-
Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis
-
Rao SM, Leo GJ, Haughton VM, et al. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989;39:161-166
-
(1989)
Neurology
, vol.39
, pp. 161-166
-
-
Rao, S.M.1
Leo, G.J.2
Haughton, V.M.3
-
15
-
-
0005167516
-
Use of neuropsychological outcome measures in multiple sclerosis clinical trials: Current status and strategies for improving MS trial design
-
Goodkin DE, Rudick RA, eds. London: Springer, in press
-
Fischer JS. Use of neuropsychological outcome measures in multiple sclerosis clinical trials: current status and strategies for improving MS trial design. In: Goodkin DE, Rudick RA, eds. Treatment of multiple sclerosis: advances in trial design, results, and future perspectives. London: Springer, 1996 (in press)
-
(1996)
Treatment of Multiple Sclerosis: Advances in Trial Design, Results, and Future Perspectives
-
-
Fischer, J.S.1
-
16
-
-
0030064625
-
Evaluating neurological outcome measures: The bare essentials
-
in press
-
Thompson A. Evaluating neurological outcome measures: the bare essentials. J Neurol Neurosurg Psychiatry 1996 (in press)
-
(1996)
J Neurol Neurosurg Psychiatry
-
-
Thompson, A.1
-
18
-
-
0001434805
-
Quantitative clinical neurological testing. I. A study of a battery of tests designed to evaluate in part the neurologic function of patients with multiple sclerosis and its use in a therapeutic trial
-
Tourtellotte WW, Haerer AF, Simpson JF, et al. Quantitative clinical neurological testing. I. A study of a battery of tests designed to evaluate in part the neurologic function of patients with multiple sclerosis and its use in a therapeutic trial. Ann NY Acad Sci 1965;122:480-505
-
(1965)
Ann NY Acad Sci
, vol.122
, pp. 480-505
-
-
Tourtellotte, W.W.1
Haerer, A.F.2
Simpson, J.F.3
-
19
-
-
0001797929
-
Methods of validating MOS health measures
-
Stewart AL, Ware JE Jr, eds. Durham, NC: Duke University Press
-
Stewart AL, Hays RD, Ware JE Jr. Methods of validating MOS health measures. In: Stewart AL, Ware JE Jr, eds. Measuring functioning and well-being. The medical outcomes study approach. Durham, NC: Duke University Press, 1993: 309-325
-
(1993)
Measuring Functioning and Well-being. The Medical Outcomes Study Approach
, pp. 309-325
-
-
Stewart, A.L.1
Hays, R.D.2
Ware Jr., J.E.3
-
20
-
-
0002027435
-
Construct validity of MOS health measures
-
Stewart AL, Ware JE Jr, eds. Durham, NC: Duke University Press
-
Hays RD, Steward AL. Construct validity of MOS health measures. In: Stewart AL, Ware JE Jr, eds. Measuring functioning and well-being. The medical outcomes study approach. Durham, NC: Duke University Press, 1993:325-345
-
(1993)
Measuring Functioning and Well-being. The Medical Outcomes Study Approach
, pp. 325-345
-
-
Hays, R.D.1
Steward, A.L.2
-
21
-
-
9544249486
-
Criteria for the choice of neuropsychological tests in clinical trials
-
Mohr E, Brouwers P, eds. Berwyn, PA: Swets & Zeitlinger
-
Albert MS. Criteria for the choice of neuropsychological tests in clinical trials. In: Mohr E, Brouwers P, eds. Handbook of clinical trials. The neurobehavioral approach. Berwyn, PA: Swets & Zeitlinger, 1991:131-139
-
(1991)
Handbook of Clinical Trials. The Neurobehavioral Approach
, pp. 131-139
-
-
Albert, M.S.1
-
23
-
-
0025314243
-
Interrater variability with the expanded disability status scale (EDSS) and functional systems (FS) in a multiple sclerosis clinical trial
-
Noseworthy JH, Vandervoort MK, Wong CJ, et al. Interrater variability with the expanded disability status scale (EDSS) and functional systems (FS) in a multiple sclerosis clinical trial. Neurology 1990;40:971-975
-
(1990)
Neurology
, vol.40
, pp. 971-975
-
-
Noseworthy, J.H.1
Vandervoort, M.K.2
Wong, C.J.3
-
24
-
-
0005295175
-
The Multiple Sclerosis Study group. Rating scales in assessment of multiple sclerosis
-
Davis R, Kondraski GV, Toutellotte WW, Syndulko K, eds. Philadelphia: Hanley and Belfus
-
Belendiuk G, Klatzman D, Mietlowski W, the Multiple Sclerosis Study group. Rating scales in assessment of multiple sclerosis. In: Davis R, Kondraski GV, Toutellotte WW, Syndulko K, eds. Quantifying neurologic performance. Philadelphia: Hanley and Belfus, 1989:177-184
-
(1989)
Quantifying Neurologic Performance
, pp. 177-184
-
-
Belendiuk, G.1
Klatzman, D.2
Mietlowski, W.3
-
25
-
-
0027413819
-
Sensitivity to change of rheumatoid arthritis clinical trial outcome measures
-
Anderson JJ, Chernoff MC. Sensitivity to change of rheumatoid arthritis clinical trial outcome measures. J Rheumatol 1993;20:535-537
-
(1993)
J Rheumatol
, vol.20
, pp. 535-537
-
-
Anderson, J.J.1
Chernoff, M.C.2
-
26
-
-
0022829003
-
Assessing the responsiveness of functional scales to clinical change: An analogy to diagnostic test performance
-
Deyo RA, Centor RM. Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chronic Dis 1986;39:897-906
-
(1986)
J Chronic Dis
, vol.39
, pp. 897-906
-
-
Deyo, R.A.1
Centor, R.M.2
-
27
-
-
0028361153
-
Structural equation modeling with longitudinal data: Strategies for examining group differences and reciprocal relationships
-
Farrell AD. Structural equation modeling with longitudinal data: strategies for examining group differences and reciprocal relationships. J Consult Clin Psychol 1994;62:477-487
-
(1994)
J Consult Clin Psychol
, vol.62
, pp. 477-487
-
-
Farrell, A.D.1
-
28
-
-
0027183595
-
A further refinement of the Reliable Change (RC) Index by improving the pre-post difference score: Introducing RC-sub(ID)
-
Hageman WJ. A further refinement of the Reliable Change (RC) Index by improving the pre-post difference score: introducing RC-sub(ID). Behav Res Ther 1993;31:693-700
-
(1993)
Behav Res Ther
, vol.31
, pp. 693-700
-
-
Hageman, W.J.1
-
29
-
-
0027731984
-
The analysis of change: Issues, fallacies, and new ideas
-
Gottman JM, Rushe RH. The analysis of change: issues, fallacies, and new ideas. J Consult Clin Psychol 1993;61:907-910
-
(1993)
J Consult Clin Psychol
, vol.61
, pp. 907-910
-
-
Gottman, J.M.1
Rushe, R.H.2
-
30
-
-
0024638447
-
Effect sizes for interpreting changes in health status
-
Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27(suppl):S178-S189
-
(1989)
Med Care
, vol.27
, Issue.SUPPL.
-
-
Kazis, L.E.1
Anderson, J.J.2
Meenan, R.F.3
-
31
-
-
0021678770
-
Outcome assessment in clinical trials. Evidence for the sensitivity of a health status measure
-
Meenan RF, Anderson JJ, Kazis LE, et al. Outcome assessment in clinical trials. Evidence for the sensitivity of a health status measure. Arthritis Rheum 1984;27:1344-1352
-
(1984)
Arthritis Rheum
, vol.27
, pp. 1344-1352
-
-
Meenan, R.F.1
Anderson, J.J.2
Kazis, L.E.3
-
32
-
-
0019185096
-
Measuring effect magnitude in repeated measures ANOVA designs: Implications for gerontological research
-
Susskind EC, Howland EW. Measuring effect magnitude in repeated measures ANOVA designs: implications for gerontological research. J Gerontol 1980;35:867-876
-
(1980)
J Gerontol
, vol.35
, pp. 867-876
-
-
Susskind, E.C.1
Howland, E.W.2
-
34
-
-
0025969095
-
Measures of effect size in the reporting of rehabilitation research
-
Ottenbacher KJ, Barrett KA. Measures of effect size in the reporting of rehabilitation research. Am J Phys Med Rehabil 1991;70(suppl):131-137
-
(1991)
Am J Phys Med Rehabil
, vol.70
, Issue.SUPPL.
, pp. 131-137
-
-
Ottenbacher, K.J.1
Barrett, K.A.2
-
36
-
-
0021035886
-
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
-
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-1452
-
(1983)
Neurology
, vol.33
, pp. 1444-1452
-
-
Kurtzke, J.F.1
-
37
-
-
0028941354
-
Methodological and statistical problems in the construction of composite measurement scales: A survey of six medical and epidemiological journals
-
Coste J, Fermanian J, Venot A. Methodological and statistical problems in the construction of composite measurement scales: a survey of six medical and epidemiological journals. Stat Med 1995;14:331-345
-
(1995)
Stat Med
, vol.14
, pp. 331-345
-
-
Coste, J.1
Fermanian, J.2
Venot, A.3
-
38
-
-
0027416977
-
Pooled outcome measures in arthritis: The pros and cons
-
Roberts RS. Pooled outcome measures in arthritis: the pros and cons. J Rheumatol 1993;20:566-567
-
(1993)
J Rheumatol
, vol.20
, pp. 566-567
-
-
Roberts, R.S.1
-
39
-
-
0010312878
-
Statistical and design considerations for multiple sclerosis clinical trials
-
Goodkin DE, Rudick RA, eds. London: Springer, in press
-
Petkau AJ. Statistical and design considerations for multiple sclerosis clinical trials. In: Goodkin DE, Rudick RA, eds. Multiple sclerosis: advances in clinical trial design, treatment, and future perspectives. London: Springer, 1996 (in press)
-
(1996)
Multiple Sclerosis: Advances in Clinical Trial Design, Treatment, and Future Perspectives
-
-
Petkau, A.J.1
-
40
-
-
0021666221
-
Procedures for comparing samples with multiple endpoints
-
O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984;40:1079-1087
-
(1984)
Biometrics
, vol.40
, pp. 1079-1087
-
-
O'Brien, P.C.1
-
42
-
-
0028270611
-
Design strategies in multiple sclerosis clinical trials
-
Ellison GW, Myers LW, Leake BD, et al. Design strategies in multiple sclerosis clinical trials. Ann Neurol 1994;36:S108-S112
-
(1994)
Ann Neurol
, vol.36
-
-
Ellison, G.W.1
Myers, L.W.2
Leake, B.D.3
-
43
-
-
0024431267
-
Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trials
-
Goodkin DE, Hertsgaard D, Rudick RA. Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trials. Arch Neurol 1989;46:1107-1112
-
(1989)
Arch Neurol
, vol.46
, pp. 1107-1112
-
-
Goodkin, D.E.1
Hertsgaard, D.2
Rudick, R.A.3
-
44
-
-
0026100007
-
Major differences in the dynamics of primary and secondary progressive multiple sclerosis
-
Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62
-
(1991)
Ann Neurol
, vol.29
, pp. 53-62
-
-
Thompson, A.J.1
Kermode, A.G.2
Wicks, D.3
-
45
-
-
0000060241
-
Treatment of multiple sclerosis with type I interferons
-
Goodkin DE, Rudick RA, eds. London: Springer, in press
-
Rudick RA, Sibley W, Durelli L. Treatment of multiple sclerosis with type I interferons. In: Goodkin DE, Rudick RA, eds. Multiple sclerosis: advances in clinical trial design, treatment, and future perspectives. London: Springer, 1996 (in press)
-
(1996)
Multiple Sclerosis: Advances in Clinical Trial Design, Treatment, and Future Perspectives
-
-
Rudick, R.A.1
Sibley, W.2
Durelli, L.3
-
46
-
-
0007927698
-
IVIg treatment in multiple sclerosis: Pilot study results and design of a placebo-controlled, double-blind clinical trial
-
Abstract
-
Noseworthy JH, Rodrigues M, An K-N, et al. IVIg treatment in multiple sclerosis: pilot study results and design of a placebo-controlled, double-blind clinical trial. Ann Neurol 1994;36: 325 (Abstract)
-
(1994)
Ann Neurol
, vol.36
, pp. 325
-
-
Noseworthy, J.H.1
Rodrigues, M.2
An, K.-N.3
-
47
-
-
0021173397
-
A neurologic rating scale (NRS) for use in multiple sclerosis
-
Sipe JC, Knobler RL, Braheny SL, et al. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology 1984;34: 1368-1372
-
(1984)
Neurology
, vol.34
, pp. 1368-1372
-
-
Sipe, J.C.1
Knobler, R.L.2
Braheny, S.L.3
|